In a deal between two United Kingdom health care products companies, Vernacare Ltd. is buying Frontier Medical Group's infection prevention business.
The deal comes five months after Chorly, England-based Vernacare was acquired by Miami-based private equity firm H.I.G. Capital.
Terms of the deal were not disclosed.
Vernacare, which was founded in 1964, makes single-use medical consumables and infection control products at two plants in northwest England. The company employs 250, and also has operations in Toronto.
The acquired business has one manufacturing plant in Blackwood, Wales, and includes the brands Sharpsafe, Clinisafe and eXchange. Frontier Medical claims Sharpsafe was the world's first purpose-designed plastic sharps container.
"Frontier's Infection Prevention business and Vernacare fit very well together, with a common focus on best practice within Infection Prevention, and together, will be even better placed to help improve Infection Prevention standards within U.K. and overseas health care systems," Vernacare CEO James Steele said in a news release.
James Mitchell, principal at H.I.G. Capital in London, added: "The Frontier Infection Prevention business is a growing industry leader in the manufacture and supply of products that contain and dispose of infectious material safely – critical systems in protecting the health care workforce and limiting the spread of infection."
He added that Vernacare will pursue similar acquisitions in the sector, across the United Kingdom and internationally.